Table 4.
Influence of vitamin D supplementation and breastfeeding on the course of disease
| Vitamin D supplementation (n = 308) |
Breastfeeding (n = 308) |
|||||
|---|---|---|---|---|---|---|
| 0–6 months | 7–12 months |
p-value
[95% CI] |
< 2 weeks | > 2 weeks |
p-value
[95% CI] |
|
| CAA, n (%) | ||||||
| Yes | 13 (11.4) | 23 (11.9) |
0.905
[−0.079–0.070] |
5 (7.6) | 31 (12.8) |
0.185
[− 0.130–0.025] |
| No | 101 (88.6) | 171 (88.1) | 61 (92.4) | 211 (87.2) | ||
| Refractory to IVIGa, n (%) | ||||||
| Yes | 9 (11.5) | 20 (14.5) |
0.543
[−0.125–0.066] |
4 (8.7) | 25 (14.7) |
0.233
[−0.160–0.039] |
| No | 69 (88.5) | 119 (85.5) | 42 (91.3) | 145 (85.3) | ||
| Laboratory, average (±SD) | ||||||
| CRP b | 93,55 (±86.703) |
105,08 (±82.948) |
0,248
[−31.119–8.057] |
103,04 (±84.499) |
100,20 (±84.539) |
0,809
[−20.255–25.942] |
| Thrombocytes c | 235.48 (±280.350) |
210.95 (±241.805) |
0.421
[−35.367–84.431] |
570.56 (±277.776) |
577.64 (±235.789) |
0.705
[−54.229–80.070] |
| Leukocytes d | 17.44 (±7.853) |
17.31 (±7.613) |
0.885
[−1.667–1.931] |
17.23 (±6.582) |
17.39 (±7.978) |
0.883
[−2.279–1.962] |
a only KD patients from 2013/2014 n = 217; b in mg/dl; c in T/μl; d in T/μl